Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model

Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)

(2014) Pieter J. Gaillard et al.   PLoS One

Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses

(2014) N. J. Roberts et al.   Science Translational Medicine

Tumor-penetrating peptide functionalization enhances the anti-glioblastoma effect of doxorubicin liposomes

(2013) Yiyi Yang et al.   NANOTECHNOLOGY

Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance

(2012) T. E. Taylor et al.   CURRENT CANCER DRUG TARGETS

Recent advances in brain tumor-targeted nano-drug delivery systems

(2012) Yu Liu et al.   Expert Opinion on Drug Delivery

Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems

(2012) Oktay Tacar et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

EGFR-Targeted Therapy in Malignant Glioma: Novel Aspects and Mechanisms of Drug Resistance

(2012) Hui-Wen Lo   Current Molecular Pharmacology

Antitumor Immunity Produced by the Liver Kupffer Cells, NK Cells, NKT Cells, and CD8+CD122+T Cells

(2011) Shuhji Seki et al.   Clinical & Developmental Immunology

Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain

(2011) Sagar Agarwal et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Corticosteroids in brain cancer patients: benefits and pitfalls

(2011) Jörg Dietrich et al.   Expert Review of Clinical Pharmacology

Biology of interleukin-10

(2010) Robert Sabat et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Biopharmaceutical drug targeting to the brain

(2010) William M. Pardridge   JOURNAL OF DRUG TARGETING

Anti-tumor immune response correlates with neurological symptoms in a dog with spontaneous astrocytoma treated by gene and vaccine therapy

(2010) G. Elizabeth Pluhar et al.   VACCINE

Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme

(2009) Benjamin Y.S. Ong et al.   BIOMATERIALS

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

(2009) J. D. Wolchok et al.   CLINICAL CANCER RESEARCH

New strategies to deliver anticancer drugs to brain tumors

(2009) Valentino Laquintana et al.   Expert Opinion on Drug Delivery

Spontaneous canine gliomas: overexpression of EGFR, PDGFRα and IGFBP2 demonstrated by tissue microarray immunophenotyping

(2009) Robert J. Higgins et al.   JOURNAL OF NEURO-ONCOLOGY

Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug

(2009) Jennifer A MacDiarmid et al.   NATURE BIOTECHNOLOGY

The Comparative Oncology Trials Consortium: Using Spontaneously Occurring Cancers in Dogs to Inform the Cancer Drug Development Pathway

(2009) Ira Gordon et al.   PLOS MEDICINE

The targeted delivery of cancer drugs across the blood–brain barrier: chemical modifications of drugs or drug-nanoparticles?

(2008) Lucienne Juillerat-Jeanneret   DRUG DISCOVERY TODAY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells

(2008) Hemant Sarin et al.   Journal of Translational Medicine